Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total published articles |
105 | 141 | 28 | 8 | 28 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
543 | 553 | 590 | 563 | 587 |
Journal total citations count | 6601 |
Journal impact factor | 6.49 |
Journal 5 years impact factor | 12.17 |
Journal cite score | 11.19 |
Journal h-index | 41 |
Journal h-index since 2019 | 26 |
Tzeng, Nian-Sheng, Yung-Ho Hsu, Shinn-Ying Ho, Yu-Ching Kuo, Hua-Chin Lee, Yun-Ju Yin, Hong-An Chen, Wen-Liang Chen, William Cheng-Chung Chu, and Hui-Ling Huang. "Is schizophrenia associated with an increased risk of chronic kidney disease? A nationwide matched-cohort study." BMJ open 5, no. 1 (2015): e006777. |
|
Sarris, Jerome, Patricia L. Gerbarg, Richard P. Brown, and Philip R. Muskin. "Integrative and complementary medicine in psychiatry." Psychiatry 1 (2015): 2261-2290. |
|
Farooq, Saeed, Abid Choudry, Dan Cohen, Farooq Naeem, and Muhammad Ayub. "Barriers to using clozapine in treatment-resistant schizophrenia: systematic review." BJPsych bulletin 43, no. 1 (2019): 8-16. |
|
Venkatasubramanian, Ganesan, and Monojit Debnath. "The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia." Progress in Neuro-Psychopharmacology and Biological Psychiatry 44 (2013): 301-311. |
|
Kelly, Deanna L., Oliver Freudenreich, MacKenzie A. Sayer, and Raymond C. Love. "Addressing barriers to clozapine underutilization: a national effort." (2018): 224-227. |
|
Chan, Man K., Michael G. Gottschalk, Frieder Haenisch, Jakub Tomasik, Tillmann Ruland, Hassan Rahmoune, Paul C. Guest, and Sabine Bahn. "Applications of blood-based protein biomarker strategies in the study of psychiatric disorders." Progress in neurobiology 122 (2014): 45-72. |
|
Tomasik, Jakub, Hassan Rahmoune, Paul C. Guest, and Sabine Bahn. "Neuroimmune biomarkers in schizophrenia." Schizophrenia research 176, no. 1 (2016): 3-13. |
|
Mele, Sonia, Raffaella Bivi, Linda Borra, Vincenzo Callegari, Stefano Caracciolo, Stefano Tugnoli, and Laila Craighero. "Efficacy of theatre activities in facial expression categorization in schizophrenia." The Arts in Psychotherapy 63 (2019): 141-150. |
|
Malhotra, Savita, Swapnajeet Sahoo, and Srinivas Balachander. "Acute and transient psychotic disorders: newer understanding." Current psychiatry reports 21, no. 11 (2019): 1-11. |
|
Lai, Chi-Yu, Elizabeth Scarr, Madhara Udawela, Ian Everall, Wei J. Chen, and Brian Dean. "Biomarkers in schizophrenia: a focus on blood based diagnostics and theranostics." World journal of psychiatry 6, no. 1 (2016): 102. |
|
Melzer, Jörg, Hans-Christian Deter, and Bernhard Uehleke. "CAM in Psychiatry." (2013). |
|
Castagnini, AC, and P. Fusar-Poli. "Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder." European Psychiatry 45 (2017): 104-113. |
|
Sabe, Michel, Othman Sentissi, and Stefan Kaiser. "Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis." Schizophrenia research 212 (2019): 15-25. |
|
Gnjatic, Sacha, Vincenzo Bronte, Laura Rosa Brunet, Marcus O. Butler, Mary L. Disis, Jérôme Galon, Leif G. Hakansson et al. "Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy." Journal for immunotherapy of cancer 5, no. 1 (2017): 1-18. |
|
Meltzer, Herbert Y., Daniel B. Share, Karu Jayathilake, Ronald M. Salomon, and Myung A. Lee. "Lurasidone improves psychopathology and cognition in treatment-resistant schizophrenia." Journal of clinical psychopharmacology 40, no. 3 (2020): 240. |
|
Leza, Juan C., Borja Garcia-Bueno, Miquel Bioque, Celso Arango, Mara Parellada, Kim Do, Patricio O’Donnell, and Miguel Bernardo. "Inflammation in schizophrenia: a question of balance." Neuroscience & Biobehavioral Reviews 55 (2015): 612-626. |
|
Cragin, Casey A., Martha B. Straus, Dawn Blacker, Laura M. Tully, and Tara A. Niendam. "Early psychosis and trauma-related disorders: clinical practice guidelines and future directions." Frontiers in psychiatry 8 (2017): 33. |
|
Leppien, Emily, Tamara Bystrak, and Bennett Doughty. "Antipsychotic agents." Side Effects of Drugs Annual 41 (2019): 51-63. |
|
Gowda, Shayanth Manche, Vijay Kumar Kg, and Ganesh Venkatasubramanian. "Retrograde Ejaculation With Second-Generation Antipsychotics in Schizophrenia: A Case Series and Literature Review." The Primary Care Companion for CNS Disorders 23, no. 2 (2021): 0-0. |
|
Pavlov, Allison, Kirstyn Kameg, Tom W. Cline, Laurel Chiapetta, Stacy Stark, and Ann M. Mitchell. "Music therapy as a nonpharmacological intervention for anxiety in patients with a thought disorder." Issues in mental health nursing 38, no. 3 (2017): 285-288. |
|